Request Deal Involvement

Perrigo completed the acquisition of HRA Pharma from Astorg and Goldman Sachs Asset Management for $1.9bn.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Dechert

legal advisors

Dechert

Rothschild & Co

financial advisors

Rothschild & Co

CG Sawaya Partners

financial advisors

CG Sawaya Partners

Goldman Sachs

financial advisors

Goldman Sachs

Sullivan & Cromwell

legal advisors

Sullivan & Cromwell

Latham & Watkins

legal advisors

Latham & Watkins

Wachtell Lipton Rosen & Katz

legal advisors

Wachtell Lipton Rosen & Katz

Centerview Partners

financial advisors

Centerview Partners

Gibson Dunn & Crutcher

legal advisors to financial advisors

Gibson Dunn & Crutcher

Brunswick Group

pr advisors

Brunswick Group

Darrois Villey Maillot Brochier

legal advisors

Darrois Villey Maillot Brochier

or

Principals

HRA PHARMA SA

target

HRA PHARMA SA

ASTORG PARTNERS SAS

vendor

ASTORG PARTNERS SAS

GOLDMAN SACHS ASSET MANAGEMENT

vendor

GOLDMAN SACHS ASSET MANAGEMENT

PERRIGO COMPANY PLC

bidder

PERRIGO COMPANY PLC

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Perrigo completed the acquisition of HRA Pharma from Astorg and Goldman Sachs Asset Management for $1.9bn.